Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study

Putta, S., Young, B. A., Levine, J. E., Reshef, R., Nakamura, R., Strouse, C., Perales, M.-A., Howard, A., Pine, P., Shi, J., Zhang, P., Ho, V. T., & Saber, W. (2023). Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study. Transplantation and Cellular Therapy, 29(3), 166.e1-166.e10. https://doi.org/10.1016/j.jtct.2022.11.024
Authors:
Santosh Putta
Bradford A. Young
John E. Levine
Ran Reshef
Ryotaro Nakamura
Christopher Strouse
Miguel-Ángel Perales
Alan Howard
Polly Pine
Shi Ju
Peixin Zhang
Vincent T. Ho
Wael Saber
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Hepatic Veno-Occlusive Disease (MeSH)
Hematopoietic Stem Cell Transplantation (MeSH)
Transplants (MeSH)
Hematopoietic Stem Cell Biology (OpenAlex Topic)
Acute Myeloid Leukemia (OpenAlex Topic)
Epidemiology and Treatment of Childhood Leukemia (OpenAlex Topic)
Author Keywords:
biomarkers
defibrotide
sinusoidal obstruction syndrome
veno-occlusive disease
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtct.2022.11.024
PMID:
36574581
DOI:
10.1016/j.jtct.2022.11.024
Journal:
Transplantation and Cellular Therapy
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: